27/05/2025
Breakthrough: Gut Bacteria Linked to Multiple Sclerosis
In a groundbreaking discovery, researchers at Ludwig Maximilian University of Munich have identified two specific gut bacteria strains that may play a direct role in triggering multiple sclerosis (MS) a chronic autoimmune disorder affecting the central nervous system.
The study involved 81 pairs of identical twins, where only one sibling in each pair had MS. By analyzing their gut microbiomes, scientists uncovered significant microbial differences most notably, the presence of Eisenbergiella tayi and Lachnoclostridium in those with MS.
To test the impact, the bacteria were introduced into mice. The result? The animals began showing MS-like neurological symptoms, offering strong experimental evidence that these microbes may influence or initiate the disease.
This research represents the strongest link to date between gut microbiota and the development of MS, marking a major shift in how we understand and potentially treat the disease.
It opens up promising paths for early detection, targeted probiotics, or microbiome-based therapies.
It supports the growing science behind the gut-brain connection in autoimmune and neurological conditions.
By reshaping the microbiome, we may soon be able to slow, prevent, or even stop MS before it progresses.
The future of MS treatment could begin in the gut.
